Codipar 15mg/500mg Capsules
*Company:
ADVANZ PharmaStatus:
UpdatedLegal Category:
Product subject to medical prescription which may not be renewed (A)Active Ingredient(s):
*Additional information is available within the SPC or upon request to the company
Updated on 08 May 2026
File name
1.3.1 PIL-Brand-Famar-Ireland-English-clean.pdf
Reasons for updating
- Change to section 2 - what you need to know - warnings and precautions
- Change to section 2 - interactions with other medicines, food or drink
- Change to section 3 - how to take/use
- Change to section 4 - possible side effects
- Change to section 5 - how to store or dispose
Free text change information supplied by the pharmaceutical company
Update Section 2 Warnings and precautions
Section section 3. How to take
Section 4. Possible side effects
Section 5. How to store
Updated on 08 May 2026
File name
1.3.1 SPC-Ireland-English-clean.pdf
Reasons for updating
- Change to section 4.2 - Posology and method of administration
- Change to section 4.4 - Special warnings and precautions for use
- Change to section 4.5 - Interaction with other medicinal products and other forms of interaction
- Change to section 4.8 - Undesirable effects
- Change to section 10 - Date of revision of the text
Legal category:Product subject to medical prescription which may not be renewed (A)
Free text change information supplied by the pharmaceutical company
Update section 4.2 Posology and method of administration – addition paragraphs ‘Treatment goals and discontinuation’ and ‘Duration of treatment’
Update section 4.4 Special warnings and precautions for use - addition paragraphs ‘Tolerance and opioid use disorder (abuse and dependence)’ , ‘Sleep-related breathing disorders’, ‘Hyperalgesia’, and ‘Hepatobiliary disorders’ – other updates
Update section 4.5 Interaction with other medicinal products and other forms of interaction – interaction gabapentinoids
Update section 4.8 Undesirable effects – addition AE ‘Sphincter of Oddi dysfunction’, addition paragraph ‘Drug dependence’
Updated on 03 December 2025
File name
Codipar 15mg 500mg Capsules_PIL.pdf
Reasons for updating
- Change to section 6 - marketing authorisation holder
- Change to section 6 - date of revision
Updated on 03 December 2025
File name
1.3.1 SPC-Ireland-English.pdf
Reasons for updating
- Change to section 7 - Marketing authorisation holder
- Change to section 10 - Date of revision of the text
Legal category:Product subject to medical prescription which may not be renewed (A)
Updated on 20 February 2025
File name
Codipar 15mg-500mg Capsules_PIL.pdf
Reasons for updating
- Change to section 2 - what you need to know - warnings and precautions
- Change to section 2 - interactions with other medicines, food or drink
- Change to section 4 - possible side effects
- Change to section 6 - date of revision
Updated on 20 February 2025
File name
Codipar 15mg_500mg Capsules_SPC.pdf
Reasons for updating
- Change to section 4.4 - Special warnings and precautions for use
- Change to section 4.5 - Interaction with other medicinal products and other forms of interaction
- Change to section 4.8 - Undesirable effects
- Change to section 10 - Date of revision of the text
Legal category:Product subject to medical prescription which may not be renewed (A)
Updated on 23 June 2023
File name
Codipar 15mg 500mg Capsules_PIL.pdf
Reasons for updating
- Change to Section 1 - what the product is
- Change to section 1 - what the product is used for
- Change to section 2 - what you need to know - contraindications
- Change to section 2 - what you need to know - warnings and precautions
- Change to section 2 - driving and using machines
- Change to section 4 - possible side effects
- Change to section 4 - how to report a side effect
- Change to section 5 - how to store or dispose
- Change to section 6 - what the product contains
- Change to section 6 - date of revision
Updated on 23 June 2023
File name
Codipar 15mg 500mg Capsules_SPC.pdf
Reasons for updating
- Change to section 3 - Pharmaceutical form
- Change to section 4.2 - Posology and method of administration
- Change to section 4.4 - Special warnings and precautions for use
- Change to section 4.8 - Undesirable effects
- Change to Section 4.8 – Undesirable effects - how to report a side effect
- Change to section 10 - Date of revision of the text
Legal category:Product subject to medical prescription which may not be renewed (A)
Free text change information supplied by the pharmaceutical company
Updated on 31 December 2021
File name
Codipar 15mg500mg Capsules_SPC_IE.pdf
Reasons for updating
- Improved presentation of SPC
Legal category:Product subject to medical prescription which may not be renewed (A)
Updated on 31 December 2021
File name
Codipar 15mg500mg Capsules_PIL_IE.pdf
Reasons for updating
- New PIL for new product
Updated on 27 September 2019
File name
1.3.1 SPC-Ireland-English_19.0.pdf
Reasons for updating
- New SPC for new product
Legal category:Product subject to medical prescription which may not be renewed (A)
ADVANZ Pharma
Address:
Unit 17 Northwood House Northwood Crescent Northwood, Dublin 9, D09 V504, IrelandMedical Information E-mail:
medicalinformation@advanzpharma.comTelephone:
+44 (0)208 588 9131Website:
https://www.advanzpharma.comMedical Information Direct Line:
+353 1800 851 119Customer Care direct line:
+353 1 5294 230